Estimates

Source: S&P Capital IQ consensus via Xpressfeed · Generated 2026-07-17.

Street snapshot

The 17 price targets span a wide $129 to $286, with a $210.76 mean sitting just above the $209 median.

Currency: USD · Scale: money in millions, absolute (per share) · Analyst counts shown explicitly; recommendation respondents: 19.

Street view Reading Analysts
Recommendation mix Buy 3, Outperform 0, Hold 15, Underperform 1, Sell 0 19
Consensus score 2.74 19
Target price mean 210.8; high 286.0; low 129.0 17

Forward table

The larger move is in earnings, where normalized EPS is modeled to more than halve to roughly $5.16 in FY2026 and then rebuild to $9.29 in FY2027, with no dividend forecast across the window.

Currency: USD · Scale: money in millions, absolute (per share) · Analyst count is the estimate count for each period and metric.

Period Metric Mean YoY Analysts Low / high
FY0E Revenue 44,277 -2.5% 15 42,247 / 45,764
FY0E EBITDA 682.8 -33.8% 9 552.4 / 749.0
FY0E EBIT 535.0 -50.8% — / —
FY0E Net income (GAAP) 153.8 -67.4% 9 72.07 / 238.5
FY0E Net income (normalized) 262.5 -64.5% — / —
FY0E EPS (GAAP) 3.32 -62.7% 7 1.41 / 4.66
FY0E EPS (normalized) 5.16 -53.2% 19 4.36 / 5.60
FY0E Free cash flow 1,861 -433.5% — / —
FY0E Dividend per share 0.00 — / —
FY0E Gross margin 12.4% -4.9% — / —
FY0E Capital expenditure -129.7 -4.6% — / —
FY0E Net debt -1,315 56.6% — / —
FY0E ROE 6.0% -63.4% — / —
FY0E Cash from operations 1,046 -529.5% — / —
FY+1E Revenue 47,524 7.3% 14 44,242 / 50,874
FY+1E EBITDA 964.2 41.2% 9 762.1 / 1,179
FY+1E EBIT 848.6 58.6% — / —
FY+1E Net income (GAAP) 488.2 217.4% 8 319.9 / 695.7
FY+1E Net income (normalized) 478.6 82.3% — / —
FY+1E EPS (GAAP) 8.34 150.9% 8 1.46 / 12.62
FY+1E EPS (normalized) 9.29 80.1% 19 3.50 / 13.50
FY+1E Free cash flow 769.6 -58.6% — / —
FY+1E Dividend per share 0.00 — / —
FY+1E Gross margin 12.6% 2.3% — / —
FY+1E Capital expenditure -151.5 16.8% — / —
FY+1E Net debt -1,854 41.0% — / —
FY+1E Cash from operations 707.6 -32.3% — / —
FY+1E ROE 10.0% 65.3% — / —
FY+2E Revenue 50,434 6.1% 10 46,498 / 55,410
FY+2E EBITDA 1,107 14.8% 7 869.4 / 1,274
FY+2E EBIT 1,077 26.9% — / —
FY+2E Net income (GAAP) 572.1 17.2% 6 400.4 / 803.0
FY+2E Net income (normalized) 650.7 36.0% — / —
FY+2E EPS (GAAP) 11.46 37.4% 5 7.85 / 15.74
FY+2E EPS (normalized) 12.93 39.1% 13 9.65 / 16.70
FY+2E Free cash flow 1,145 48.8% — / —
FY+2E Dividend per share 0.00 — / —
FY+2E Gross margin 12.9% 1.8% — / —
FY+2E Capital expenditure -165.4 9.1% — / —
FY+2E Net debt -2,531 36.5% — / —
FY+2E Cash from operations 911.7 28.8% — / —
FY+2E ROE 10.8% 8.7% — / —
Q2 FY2026 Revenue 10,781 -5.7% 13 10,218 / 11,056
Q2 FY2026 EBITDA 174.0 -61.3% 7 158.2 / 197.9
Q2 FY2026 EBIT 144.2 -67.2% — / —
Q2 FY2026 Net income (GAAP) 60.23 -76.4% 8 44.00 / 89.20
Q2 FY2026 Net income (normalized) 74.74 -74.6% — / —
Q2 FY2026 EPS (GAAP) 1.25 -73.6% 6 0.87 / 1.75
Q2 FY2026 EPS (normalized) 1.40 -74.4% 18 0.98 / 2.04
Q2 FY2026 Free cash flow -82.00 -130.6% — / —
Q2 FY2026 Dividend per share 0.00 — / —
Q2 FY2026 Gross margin 12.2% -17.1% — / —
Q2 FY2026 Capital expenditure -33.45 3.2% — / —
Q2 FY2026 Net debt -1,803 26.5% — / —
Q2 FY2026 ROE 7.5% -70.9% — / —
Q2 FY2026 Cash from operations -312.1 -226.9% — / —
Q3 FY2026 Revenue 10,901 -5.0% 13 10,207 / 11,271
Q3 FY2026 EBITDA 174.2 -5.8% 7 136.3 / 221.5
Q3 FY2026 EBIT 141.5 -54.6% — / —
Q3 FY2026 Net income (GAAP) 51.25 -35.1% 8 30.05 / 81.51
Q3 FY2026 Net income (normalized) 58.46 -71.9% — / —
Q3 FY2026 EPS (GAAP) 1.05 -30.3% 6 0.59 / 1.59
Q3 FY2026 EPS (normalized) 1.27 -31.1% 18 0.73 / 1.92
Q3 FY2026 Free cash flow 123.0 -25.0% — / —
Q3 FY2026 Dividend per share 0.00 — / —
Q3 FY2026 Gross margin 12.3% -11.4% — / —
Q3 FY2026 Capital expenditure -33.92 3.1% — / —
Q3 FY2026 Net debt -1,876 48.6% — / —
Q3 FY2026 ROE 8.7% -48.4% — / —
Q3 FY2026 Cash from operations 194.4 56.7% — / —
Q4 FY2026 Revenue 11,843 4.1% 13 11,064 / 12,640
Q4 FY2026 EBITDA 107.6 -198.7% 6 55.38 / 139.0
Q4 FY2026 EBIT 65.39 -1.9% — / —
Q4 FY2026 Net income (GAAP) -7.93 -95.0% 8 -73.51 / 22.54
Q4 FY2026 Net income (normalized) 6.39 -41.5% — / —
Q4 FY2026 EPS (GAAP) -0.14 -95.4% 6 -1.44 / 0.42
Q4 FY2026 EPS (normalized) 0.13 -104.7% 18 -1.15 / 0.85
Q4 FY2026 Free cash flow 409.0 — / —
Q4 FY2026 Dividend per share 0.00 — / —
Q4 FY2026 Gross margin 11.4% 6.9% — / —
Q4 FY2026 Capital expenditure -36.17 11.5% — / —
Q4 FY2026 Net debt -2,122 306.4% — / —
Q4 FY2026 Cash from operations 174.6 -893.5% — / —
Q4 FY2026 ROE -1.1% -169.2% — / —
Q1 FY2027 Revenue 11,389 5.5% 6 10,612 / 12,229
Q1 FY2027 EBITDA 290.6 77.2% 5 235.3 / 396.4
Q1 FY2027 EBIT 271.6 53.9% — / —
Q1 FY2027 Net income (GAAP) 158.3 1030.5% 5 113.6 / 232.4
Q1 FY2027 Net income (normalized) 177.2 78.7% — / —
Q1 FY2027 EPS (GAAP) 3.04 1027.0% 4 2.23 / 4.58
Q1 FY2027 EPS (normalized) 2.96 26.0% 11 1.98 / 4.79
Q1 FY2027 Dividend per share 0.00 — / —
Q1 FY2027 Gross margin 13.2% 11.3% — / —
Q1 FY2027 Capital expenditure -40.76 23.5% — / —
Q1 FY2027 Net debt -2,175 277.5% — / —
Q1 FY2027 ROE 23.0% 153.7% — / —
Q1 FY2027 Cash from operations 177.0 -76.8% — / —

Estimate momentum

Those reductions largely predate the last 30 days, over which both years' revenue and EPS have been broadly stable to slightly higher.

Currency: USD · Scale: money in millions, absolute (per share) · Point-in-time consensus; analyst count is shown where supplied.

Period Metric Lookback Then Now Direction / magnitude Analysts
2028 Revenue 30d 49,540 50,434 up 1.8%
2028 Revenue 90d 49,155 50,434 up 2.6%
2028 Revenue 180d 52,122 50,434 down 3.2%
2027 EPS (normalized) 30d 9.26 9.29 up 0.3%
2027 EPS (normalized) 90d 8.20 9.29 up 13.4%
2027 EPS (normalized) 180d 16.34 9.29 down 43.1%
2027 Revenue 30d 47,249 47,524 up 0.6%
2027 Revenue 90d 46,671 47,524 up 1.8%
2027 Revenue 180d 50,371 47,524 down 5.7%
2028 EPS (normalized) 30d 12.34 12.93 up 4.8%
2028 EPS (normalized) 90d 12.51 12.93 up 3.4%
2028 EPS (normalized) 180d 25.09 12.93 down 48.4%

Beat / miss record

Current sequences by metric: Revenue: 1 consecutive miss; EPS (normalized): 1 consecutive beat.

Currency: USD · Scale: money in millions, absolute (per share) · Consensus is captured before each actual first became effective; analyst count shown per observation.

Quarter Metric Consensus as of Actual Surprise Outcome Analysts
Q1 FY2026 Revenue 10,886 10,796 -0.8% Miss
Q1 FY2026 EPS (normalized) 1.91 2.35 23.0% Beat
Q4 FY2025 Revenue 10,905 11,375 4.3% Beat
Q4 FY2025 EPS (normalized) 0.33 -2.75 -921.5% Miss
Q3 FY2025 Revenue 10,984 11,477 4.5% Beat
Q3 FY2025 EPS (normalized) 3.89 1.84 -52.7% Miss
Q2 FY2025 Revenue 10,941 11,427 4.4% Beat
Q2 FY2025 EPS (normalized) 5.53 5.48 -0.9% Miss
Q1 FY2025 Revenue 10,814 11,147 3.1% Beat
Q1 FY2025 EPS (normalized) 5.96 6.08 2.1% Beat
Q4 FY2024 Revenue 10,319 10,499 1.7% Beat
Q4 FY2024 EPS (normalized) 5.88 5.05 -14.2% Miss
Q3 FY2024 Revenue 9,912 10,340 4.3% Beat
Q3 FY2024 EPS (normalized) 5.94 6.01 1.1% Beat
Q2 FY2024 Revenue 9,754 9,880 1.3% Beat
Q2 FY2024 EPS (normalized) 5.68 5.86 3.2% Beat

Where the street disagrees

Currency: USD · Scale: money in millions, absolute (per share) · Dispersion is high-low divided by absolute mean; analyst count shown per item.

Period Metric Mean Low High Spread / mean Analysts
Q4 FY2026 EPS (normalized) 0.13 -1.15 0.85 1563.0% 18
Q4 FY2026 EPS (GAAP) -0.14 -1.44 0.42 1287.7% 6
Q4 FY2026 Net income (GAAP) -7.93 -73.51 22.54 1210.8% 8
Q4 FY2025 Net income (GAAP) -5.11 -34.71 15.00 973.5% 7
Q4 FY2025 EPS (GAAP) -0.17 -0.68 0.15 478.2% 5